FDA Orange Book
Generic for Nasonex
Nasonex contains mometasone furoate. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Nasonex is mometasone furoate. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
Run it in Rivvi
Map Nasonex and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Nasonex products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| spray, metered, nasal | 0.05MG/SPRAY | Discontinued | None | 4 | AB |
NDA 020762, held by ORGANON LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic mometasone furoate
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| APOTEX INC | 091161 | AB (A-rated, therapeutically equivalent) | March 22, 2016 | 0.05MG/SPRAY |
| AMNEAL PHARMACEUTICALS | 207989 | AB (A-rated, therapeutically equivalent) | April 3, 2017 | 0.05MG/SPRAY |
| AUROBINDO PHARMA LTD | 215878 | AB (A-rated, therapeutically equivalent) | March 18, 2024 | 0.05MG/SPRAY |
| NASPRESS PHARMACEUTICAL CO LTD | 211706 | AB (A-rated, therapeutically equivalent) | May 15, 2025 | 0.05MG/SPRAY |
Questions
Is there a generic for Nasonex?
Yes. The generic name for Nasonex is mometasone furoate. 4 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.
What is the generic name for Nasonex?
The active ingredient in Nasonex is mometasone furoate, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.